FB Rice names Melbourne biotech partners
Australian independent IP firm FB Rice has promoted two new Melbourne partners in a bid to strengthen its biotechnology and chemistry practice.
The company has named Dr Patrick McManamny and Dr Marcus Caulfield as its newest partners. Both appointees have been working at FB Rice since 2002.
Dr McManamny is part of the firm’s biotechnology team. He advises clients on patent validity and management issues, focusing on biological drugs such as antibodies and stem cells, as well as diagnostics and drug screening technologies.
Dr Caulfield’s expertise is in organic and polymer chemistry, and he advises companies in both the animal and human health segments.
Both new partners also have clients including universities, hospitals, cooperative research centres and research institutes.
FB Rice was founded over 60 years ago and has been operating in Melbourne for the past 20 years.
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
Australia announces $7.2m diphtheria outbreak response package
To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...
MV Hondius passengers return to Australia under strict infection control measures
The Australian CDC has provided an update on hantavirus risk to Australians and infection...
